 | • レポートコード：MRC2-11QY05442 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は薬剤溶出性生体吸収性ステントのグローバル市場について調査・分析したレポートです。種類別（セロリムス・パクリタキセル薬剤溶出ステント、シロリムス薬剤溶出ステント）市場規模、用途別（冠状動脈疾患、末梢動脈疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別薬剤溶出性生体吸収性ステントの競争状況、市場シェア ・世界の薬剤溶出性生体吸収性ステント市場：種類別市場規模 2015年-2020年（セロリムス・パクリタキセル薬剤溶出ステント、シロリムス薬剤溶出ステント） ・世界の薬剤溶出性生体吸収性ステント市場：種類別市場規模予測 2021年-2026年（セロリムス・パクリタキセル薬剤溶出ステント、シロリムス薬剤溶出ステント） ・世界の薬剤溶出性生体吸収性ステント市場：用途別市場規模 2015年-2020年（冠状動脈疾患、末梢動脈疾患） ・世界の薬剤溶出性生体吸収性ステント市場：用途別市場規模予測 2021年-2026年（冠状動脈疾患、末梢動脈疾患） ・北米の薬剤溶出性生体吸収性ステント市場分析：米国、カナダ ・ヨーロッパの薬剤溶出性生体吸収性ステント市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの薬剤溶出性生体吸収性ステント市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の薬剤溶出性生体吸収性ステント市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの薬剤溶出性生体吸収性ステント市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Medtronic、B.Braun Melsungen、Abbott Laboratories、Boston Scientific Corporation、Biosensors International、Terumo Corporation.、MicroPort Scientific Corporation、Alvimedica、Biotronik、Elixir Medical Corporation、Innovative Health Technologies ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Drug-Eluting Bioabsorbable Stents Market
The global Drug-Eluting Bioabsorbable Stents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Drug-Eluting Bioabsorbable Stents Scope and Market Size
Drug-Eluting Bioabsorbable Stents market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug-Eluting Bioabsorbable Stents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Drug-Eluting Bioabsorbable Stents market is segmented into
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Segment by Application, the Drug-Eluting Bioabsorbable Stents market is segmented into
Coronary Artery Diseases
Peripheral Artery Diseases
Regional and Country-level Analysis
The Drug-Eluting Bioabsorbable Stents market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug-Eluting Bioabsorbable Stents market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Drug-Eluting Bioabsorbable Stents Market Share Analysis
Drug-Eluting Bioabsorbable Stents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drug-Eluting Bioabsorbable Stents business, the date to enter into the Drug-Eluting Bioabsorbable Stents market, Drug-Eluting Bioabsorbable Stents product introduction, recent developments, etc.
The major vendors covered:
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies
1 Study Coverage
1.1 Drug-Eluting Bioabsorbable Stents Product Introduction
1.2 Market Segments
1.3 Key Drug-Eluting Bioabsorbable Stents Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Type
1.4.2 Serolimus and Paclitaxel Drug-Eluting Stents
1.4.3 Sirolimus Drug Eluting Stents
1.5 Market by Application
1.5.1 Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Application
1.5.2 Coronary Artery Diseases
1.5.3 Peripheral Artery Diseases
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Drug-Eluting Bioabsorbable Stents Market Size, Estimates and Forecasts
2.1.1 Global Drug-Eluting Bioabsorbable Stents Revenue 2015-2026
2.1.2 Global Drug-Eluting Bioabsorbable Stents Sales 2015-2026
2.2 Global Drug-Eluting Bioabsorbable Stents, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Drug-Eluting Bioabsorbable Stents Competitor Landscape by Players
3.1 Drug-Eluting Bioabsorbable Stents Sales by Manufacturers
3.1.1 Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2015-2020)
3.1.2 Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers (2015-2020)
3.2 Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers
3.2.1 Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers (2015-2020)
3.2.2 Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Drug-Eluting Bioabsorbable Stents Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Drug-Eluting Bioabsorbable Stents Revenue in 2019
3.2.5 Global Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Drug-Eluting Bioabsorbable Stents Price by Manufacturers
3.4 Drug-Eluting Bioabsorbable Stents Manufacturing Base Distribution, Product Types
3.4.1 Drug-Eluting Bioabsorbable Stents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drug-Eluting Bioabsorbable Stents Product Type
3.4.3 Date of International Manufacturers Enter into Drug-Eluting Bioabsorbable Stents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Type (2015-2020)
4.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020)
4.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2015-2020)
4.1.3 Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Drug-Eluting Bioabsorbable Stents Market Size Forecast by Type (2021-2026)
4.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Type (2021-2026)
4.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Type (2021-2026)
4.2.3 Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Drug-Eluting Bioabsorbable Stents Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Application (2015-2020)
5.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020)
5.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2015-2020)
5.1.3 Drug-Eluting Bioabsorbable Stents Price by Application (2015-2020)
5.2 Drug-Eluting Bioabsorbable Stents Market Size Forecast by Application (2021-2026)
5.2.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Application (2021-2026)
5.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Application (2021-2026)
5.2.3 Global Drug-Eluting Bioabsorbable Stents Price Forecast by Application (2021-2026)
6 North America
6.1 North America Drug-Eluting Bioabsorbable Stents by Country
6.1.1 North America Drug-Eluting Bioabsorbable Stents Sales by Country
6.1.2 North America Drug-Eluting Bioabsorbable Stents Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type
6.3 North America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application
7 Europe
7.1 Europe Drug-Eluting Bioabsorbable Stents by Country
7.1.1 Europe Drug-Eluting Bioabsorbable Stents Sales by Country
7.1.2 Europe Drug-Eluting Bioabsorbable Stents Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type
7.3 Europe Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Drug-Eluting Bioabsorbable Stents by Region
8.1.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region
8.1.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type
8.3 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application
9 Latin America
9.1 Latin America Drug-Eluting Bioabsorbable Stents by Country
9.1.1 Latin America Drug-Eluting Bioabsorbable Stents Sales by Country
9.1.2 Latin America Drug-Eluting Bioabsorbable Stents Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type
9.3 Central & South America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents by Country
10.1.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Country
10.1.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Type
10.3 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Application
11 Company Profiles
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Description and Business Overview
11.1.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Products Offered
11.1.5 Medtronic Related Developments
11.2 B.Braun Melsungen
11.2.1 B.Braun Melsungen Corporation Information
11.2.2 B.Braun Melsungen Description and Business Overview
11.2.3 B.Braun Melsungen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Products Offered
11.2.5 B.Braun Melsungen Related Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Corporation Information
11.3.2 Abbott Laboratories Description and Business Overview
11.3.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Products Offered
11.3.5 Abbott Laboratories Related Developments
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Corporation Information
11.4.2 Boston Scientific Corporation Description and Business Overview
11.4.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Products Offered
11.4.5 Boston Scientific Corporation Related Developments
11.5 Biosensors International
11.5.1 Biosensors International Corporation Information
11.5.2 Biosensors International Description and Business Overview
11.5.3 Biosensors International Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Products Offered
11.5.5 Biosensors International Related Developments
11.6 Terumo Corporation.
11.6.1 Terumo Corporation. Corporation Information
11.6.2 Terumo Corporation. Description and Business Overview
11.6.3 Terumo Corporation. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Products Offered
11.6.5 Terumo Corporation. Related Developments
11.7 MicroPort Scientific Corporation
11.7.1 MicroPort Scientific Corporation Corporation Information
11.7.2 MicroPort Scientific Corporation Description and Business Overview
11.7.3 MicroPort Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
11.7.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Products Offered
11.7.5 MicroPort Scientific Corporation Related Developments
11.8 Alvimedica
11.8.1 Alvimedica Corporation Information
11.8.2 Alvimedica Description and Business Overview
11.8.3 Alvimedica Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Products Offered
11.8.5 Alvimedica Related Developments
11.9 Biotronik
11.9.1 Biotronik Corporation Information
11.9.2 Biotronik Description and Business Overview
11.9.3 Biotronik Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Products Offered
11.9.5 Biotronik Related Developments
11.10 Elixir Medical Corporation
11.10.1 Elixir Medical Corporation Corporation Information
11.10.2 Elixir Medical Corporation Description and Business Overview
11.10.3 Elixir Medical Corporation Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Products Offered
11.10.5 Elixir Medical Corporation Related Developments
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Description and Business Overview
11.1.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Products Offered
11.1.5 Medtronic Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Drug-Eluting Bioabsorbable Stents Market Estimates and Projections by Region
12.1.1 Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Regions 2021-2026
12.1.2 Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Regions 2021-2026
12.2 North America Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026)
12.2.1 North America: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026)
12.2.2 North America: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026)
12.2.3 North America: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026)
12.3 Europe Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026)
12.3.1 Europe: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026)
12.3.2 Europe: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026)
12.3.3 Europe: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Region (2021-2026)
12.5 Latin America Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026)
12.5.1 Latin America: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026)
12.5.2 Latin America: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026)
12.5.3 Latin America: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Drug-Eluting Bioabsorbable Stents Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Drug-Eluting Bioabsorbable Stents Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Drug-Eluting Bioabsorbable Stents Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Drug-Eluting Bioabsorbable Stents Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drug-Eluting Bioabsorbable Stents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Drug-Eluting Bioabsorbable Stents Market Segments
Table 2. Ranking of Global Top Drug-Eluting Bioabsorbable Stents Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Serolimus and Paclitaxel Drug-Eluting Stents
Table 5. Major Manufacturers of Sirolimus Drug Eluting Stents
Table 6. Global Drug-Eluting Bioabsorbable Stents Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Drug-Eluting Bioabsorbable Stents Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Drug-Eluting Bioabsorbable Stents Sales by Regions 2015-2020 (K Units)
Table 9. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Regions (2015-2020)
Table 10. Global Drug-Eluting Bioabsorbable Stents Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Drug-Eluting Bioabsorbable Stents Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Drug-Eluting Bioabsorbable Stents Sales Share by Manufacturers (2015-2020)
Table 13. Global Drug-Eluting Bioabsorbable Stents Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Drug-Eluting Bioabsorbable Stents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug-Eluting Bioabsorbable Stents as of 2019)
Table 15. Drug-Eluting Bioabsorbable Stents Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Drug-Eluting Bioabsorbable Stents Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Drug-Eluting Bioabsorbable Stents Price (2015-2020) (USD/Unit)
Table 18. Drug-Eluting Bioabsorbable Stents Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Drug-Eluting Bioabsorbable Stents Product Type
Table 20. Date of International Manufacturers Enter into Drug-Eluting Bioabsorbable Stents Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units)
Table 23. Global Drug-Eluting Bioabsorbable Stents Sales Share by Type (2015-2020)
Table 24. Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Drug-Eluting Bioabsorbable Stents Revenue Share by Type (2015-2020)
Table 26. Drug-Eluting Bioabsorbable Stents Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units)
Table 28. Global Drug-Eluting Bioabsorbable Stents Sales Share by Application (2015-2020)
Table 29. North America Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units)
Table 30. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020)
Table 31. North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020)
Table 33. North America Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units)
Table 34. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020)
Table 35. North America Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units)
Table 36. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020)
Table 37. Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units)
Table 38. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020)
Table 39. Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020)
Table 41. Europe Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units)
Table 42. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020)
Table 43. Europe Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units)
Table 44. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020)
Table 53. Latin America Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units)
Table 54. Latin America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020)
Table 57. Latin America Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units)
Table 58. Latin America Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020)
Table 59. Latin America Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units)
Table 60. Latin America Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020)
Table 69. Medtronic Corporation Information
Table 70. Medtronic Description and Major Businesses
Table 71. Medtronic Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Medtronic Product
Table 73. Medtronic Recent Development
Table 74. B.Braun Melsungen Corporation Information
Table 75. B.Braun Melsungen Description and Major Businesses
Table 76. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. B.Braun Melsungen Product
Table 78. B.Braun Melsungen Recent Development
Table 79. Abbott Laboratories Corporation Information
Table 80. Abbott Laboratories Description and Major Businesses
Table 81. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Abbott Laboratories Product
Table 83. Abbott Laboratories Recent Development
Table 84. Boston Scientific Corporation Corporation Information
Table 85. Boston Scientific Corporation Description and Major Businesses
Table 86. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Boston Scientific Corporation Product
Table 88. Boston Scientific Corporation Recent Development
Table 89. Biosensors International Corporation Information
Table 90. Biosensors International Description and Major Businesses
Table 91. Biosensors International Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Biosensors International Product
Table 93. Biosensors International Recent Development
Table 94. Terumo Corporation. Corporation Information
Table 95. Terumo Corporation. Description and Major Businesses
Table 96. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Terumo Corporation. Product
Table 98. Terumo Corporation. Recent Development
Table 99. MicroPort Scientific Corporation Corporation Information
Table 100. MicroPort Scientific Corporation Description and Major Businesses
Table 101. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. MicroPort Scientific Corporation Product
Table 103. MicroPort Scientific Corporation Recent Development
Table 104. Alvimedica Corporation Information
Table 105. Alvimedica Description and Major Businesses
Table 106. Alvimedica Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Alvimedica Product
Table 108. Alvimedica Recent Development
Table 109. Biotronik Corporation Information
Table 110. Biotronik Description and Major Businesses
Table 111. Biotronik Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Biotronik Product
Table 113. Biotronik Recent Development
Table 114. Elixir Medical Corporation Corporation Information
Table 115. Elixir Medical Corporation Description and Major Businesses
Table 116. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Elixir Medical Corporation Product
Table 118. Elixir Medical Corporation Recent Development
Table 119. Innovative Health Technologies Corporation Information
Table 120. Innovative Health Technologies Description and Major Businesses
Table 121. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Innovative Health Technologies Product
Table 123. Innovative Health Technologies Recent Development
Table 124. Global Drug-Eluting Bioabsorbable Stents Sales Forecast by Regions (2021-2026) (K Units)
Table 125. Global Drug-Eluting Bioabsorbable Stents Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Drug-Eluting Bioabsorbable Stents Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2021-2026) (K Units)
Table 129. North America: Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2021-2026) (K Units)
Table 131. Europe: Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Drug-Eluting Bioabsorbable Stents Sales Forecast by Region (2021-2026) (K Units)
Table 133. Asia Pacific: Drug-Eluting Bioabsorbable Stents Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2021-2026) (K Units)
Table 135. Latin America: Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Drug-Eluting Bioabsorbable Stents Sales Forecast by Country (2021-2026) (K Units)
Table 137. Middle East and Africa: Drug-Eluting Bioabsorbable Stents Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Drug-Eluting Bioabsorbable Stents Players
Table 142. Drug-Eluting Bioabsorbable Stents Customers List
Table 143. Drug-Eluting Bioabsorbable Stents Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug-Eluting Bioabsorbable Stents Product Picture
Figure 2. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type in 2020 & 2026
Figure 3. Serolimus and Paclitaxel Drug-Eluting Stents Product Picture
Figure 4. Sirolimus Drug Eluting Stents Product Picture
Figure 5. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2020 & 2026
Figure 6. Coronary Artery Diseases
Figure 7. Peripheral Artery Diseases
Figure 8. Drug-Eluting Bioabsorbable Stents Report Years Considered
Figure 9. Global Drug-Eluting Bioabsorbable Stents Market Size 2015-2026 (US$ Million)
Figure 10. Global Drug-Eluting Bioabsorbable Stents Sales 2015-2026 (K Units)
Figure 11. Global Drug-Eluting Bioabsorbable Stents Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region (2015-2020)
Figure 13. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2019
Figure 14. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region (2015-2020)
Figure 15. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region in 2019
Figure 16. Global Drug-Eluting Bioabsorbable Stents Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Drug-Eluting Bioabsorbable Stents Revenue in 2019
Figure 18. Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2015-2020)
Figure 20. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type in 2019
Figure 21. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2015-2020)
Figure 22. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type in 2019
Figure 23. Global Drug-Eluting Bioabsorbable Stents Market Share by Price Range (2015-2020)
Figure 24. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2015-2020)
Figure 25. Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application in 2019
Figure 26. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application (2015-2020)
Figure 27. Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application in 2019
Figure 28. North America Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2019
Figure 31. North America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2019
Figure 32. U.S. Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Drug-Eluting Bioabsorbable Stents Market Share by Type in 2019
Figure 37. North America Drug-Eluting Bioabsorbable Stents Market Share by Application in 2019
Figure 38. Europe Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2019
Figure 41. Europe Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2019
Figure 42. Germany Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Drug-Eluting Bioabsorbable Stents Market Share by Type in 2019
Figure 53. Europe Drug-Eluting Bioabsorbable Stents Market Share by Application in 2019
Figure 54. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Market Share by Region in 2019
Figure 57. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Market Share by Region in 2019
Figure 58. China Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Drug-Eluting Bioabsorbable Stents Market Share by Type in 2019
Figure 81. Asia Pacific Drug-Eluting Bioabsorbable Stents Market Share by Application in 2019
Figure 82. Latin America Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2019
Figure 85. Latin America Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2019
Figure 86. Mexico Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Drug-Eluting Bioabsorbable Stents Market Share by Type in 2019
Figure 93. Latin America Drug-Eluting Bioabsorbable Stents Market Share by Application in 2019
Figure 94. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue Market Share by Country in 2019
Figure 98. Turkey Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Drug-Eluting Bioabsorbable Stents Sales Growth Rate (2015-2020) (K Units)
Figure 103. U.A.E Drug-Eluting Bioabsorbable Stents Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Share by Type in 2019
Figure 105. Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Share by Application in 2019
Figure 106. North America Drug-Eluting Bioabsorbable Stents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Drug-Eluting Bioabsorbable Stents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Drug-Eluting Bioabsorbable Stents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Drug-Eluting Bioabsorbable Stents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Drug-Eluting Bioabsorbable Stents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Drug-Eluting Bioabsorbable Stents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Drug-Eluting Bioabsorbable Stents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
薬剤溶出性バルーン（DEB）の世界市場（～2026年） Market Analysis and Insights: Global Drug Eluting Balloons（DEB） Market The global Drug Eluting Balloons（DEB） market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Drug Eluting Balloons（DEB） Scope and Market Size Drug Eluting…- 薬剤溶出性ビーズの世界市場（～2026年） Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic o…
- 生体吸収性冠動脈ステントの世界市場（～2026年） Placement of these bioresorbable devices enable individuals to live with a normal functioning artery as well as the option to undergo an angioplasty in their later years. While still in development stage, the pediatric patient cohort with genetic coronary conditions are a viable target for these ful…
- 徐放性ドラッグデリバリーの世界市場（～2026年） Controlled drug delivery is one which delivers the drug at a predetermined rate, for locally or systemically, for a specified period of time. Controlled drug delivery systems can include the maintenance of druglevels within a desired range, the need for fewer administrations, optimal use of the drug…
- 放出制御型ドラッグデリバリー技術の世界市場（～2026年） Market Analysis and Insights: Global Controlled-Release Drug Delivery Technology Market The global Controlled-Release Drug Delivery Technology market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Controlled-Release Drug Del…